| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 23, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$185.00
Est. +18%
|
$157.19 | $175.65 |
Pending
|
$174.48
+11.0%
|
| Oct 12, 2026 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$76.00
Est. +32%
|
$57.58 | $64.24 |
Pending
|
$64.20
+11.5%
|
| Sep 23, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$640.00
Est. +24%
|
$514.99 | $568.67 |
Pending
|
$549.04
+6.6%
|
| Sep 23, 2026 |
AMGEN Inc.
AMGN
|
SELL |
$410.00
Est. +0%
|
$410.24 | $396.18 (Low) |
Target Met
|
$478.48
-16.6%
|
| Sep 01, 2026 |
Latigo Biotherapeutics Inc.
LTGO
|
BUY |
$50.00
Est. +127%
|
$22.02 | - | - |
$0.00
-100.0%
|
| Aug 31, 2026 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$105.00
Est. +60%
|
$65.53 | $67.55 |
Pending
|
$57.11
-12.8%
|
| Mar 13, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,300.00
Est. +30%
|
$1,000.78 | $1,449.68 |
Target Met
|
$1,417.83
+41.7%
|
| Mar 12, 2026 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$103.00
Est. +72%
|
$59.86 | $70.98 |
Pending
|
$57.11
-4.6%
|
| Mar 10, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$180.00
Est. +22%
|
$146.94 | $175.65 |
Precision Hit (±3%)
|
$174.48
+18.7%
|
| Mar 10, 2026 |
AMGEN Inc.
AMGN
|
SELL |
$350.00
Est. +6%
|
$373.08 | $320.53 (Low) |
Target Met
|
$478.48
-28.3%
|
| Mar 10, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$580.00
Est. +17%
|
$496.50 | $568.67 |
Precision Hit (±3%)
|
$549.04
+10.6%
|
| Mar 10, 2026 |
BioNTech SE - ADR
BNTX
|
BUY |
$138.00
Est. +65%
|
$83.89 | $116.87 |
Pending
|
$90.70
+8.1%
|
| Feb 02, 2026 |
Apogee Therapeutics Inc.
APGE
|
BUY |
$95.00
Est. +44%
|
$65.99 | $135.10 |
Target Met
|
$135.07
+104.7%
|
| Jan 09, 2026 |
Cytokinetics Inc
CYTK
|
BUY |
$90.00
Est. +42%
|
$63.24 | $88.31 |
Precision Hit (±3%)
|
$63.60
+0.6%
|
| Dec 10, 2025 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$70.00
Est. +56%
|
$44.83 | $53.18 |
Pending
|
$52.95
+18.1%
|
| Oct 29, 2025 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$174.00
Est. +18%
|
$147.38 | $186.12 |
Target Met
|
$166.05
+12.7%
|
| Oct 28, 2025 |
Alkermes plc
ALKS
|
BUY |
$56.00
Est. +82%
|
$30.75 | $55.67 |
Bullseye Hit (±1%)
|
$45.89
+49.2%
|
| Oct 01, 2025 |
Enanta Pharmaceuticals Inc
ENTA
|
BUY |
$20.00
Est. +84%
|
$10.88 | $17.15 |
Miss
|
$10.65
-2.1%
|
| Apr 23, 2025 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$68.00
Est. +40%
|
$48.52 | $62.89 |
Miss
|
$64.20
+32.3%
|
| Nov 15, 2024 |
Merck & Co Inc
MRK
|
BUY |
$148.00
Est. +50%
|
$98.36 | $105.07 |
Miss
|
$150.39
+52.9%
|
| Oct 15, 2024 |
Exelixis Inc
EXEL
|
BUY |
$33.00
Est. +15%
|
$28.80 | $49.40 |
Target Met
|
$72.75
+152.6%
|
| Sep 17, 2024 |
BioNTech SE - ADR
BNTX
|
BUY |
$150.00
Est. +21%
|
$123.97 | $131.49 |
Miss
|
$90.70
-26.8%
|
| Sep 13, 2024 |
BioNTech SE - ADR
BNTX
|
SELL |
$96.00
Est. +9%
|
$105.00 | $81.20 (Low) |
Target Met
|
$90.70
+13.6%
|
| Sep 10, 2024 |
Relay Therapeutics Inc
RLAY
|
BUY |
$16.00
Est. +68%
|
$9.51 | $10.13 |
Miss
|
$18.01
+89.4%
|
| Aug 15, 2024 |
Merck & Co Inc
MRK
|
BUY |
$147.00
Est. +30%
|
$113.49 | $120.30 |
Miss
|
$150.39
+32.5%
|
| Aug 08, 2024 |
Apellis Pharmaceuticals Inc
APLS
|
BUY |
$82.00
Est. +118%
|
$37.66 | $41.94 |
Miss
|
$41.03
+8.9%
|
| Jul 22, 2024 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$77.00
Est. +52%
|
$50.61 | $52.34 |
Miss
|
$40.15
-20.7%
|
| Jul 16, 2024 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$75.00
Est. +50%
|
$49.84 | $52.34 |
Miss
|
$40.15
-19.4%
|
| Jun 24, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,015.00
Est. +15%
|
$883.88 | $972.53 |
Miss
|
$1,417.83
+60.4%
|
| Jun 18, 2024 |
Zentalis Pharmaceuticals Inc
ZNTL
|
BUY |
$6.00
Est. +39%
|
$4.31 | $5.44 |
Miss
|
$1.76
-59.2%
|
| Jun 06, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$957.00
Est. +14%
|
$837.29 | $972.53 |
Precision Hit (±3%)
|
$1,417.83
+69.3%
|
| May 23, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$925.00
Est. +15%
|
$805.06 | $972.53 |
Target Met
|
$1,417.83
+76.1%
|
| May 23, 2024 |
Cytokinetics Inc
CYTK
|
BUY |
$85.00
Est. +44%
|
$59.23 | $61.37 |
Miss
|
$63.60
+7.4%
|
| May 20, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$915.00
Est. +19%
|
$770.00 | $972.53 |
Target Met
|
$1,417.83
+84.1%
|
| Apr 12, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,060.00
Est. +16%
|
$911.78 | $1,211.20 |
Target Met
|
$930.67
+2.1%
|
| Apr 10, 2024 |
Alkermes plc
ALKS
|
BUY |
$50.00
Est. +274%
|
$13.37 | $36.45 |
Miss
|
$45.89
+243.2%
|
| Apr 09, 2024 |
Alkermes plc
ALKS
|
SELL |
$25.00
Est. +7%
|
$26.95 | $22.90 (Low) |
Target Met
|
$45.89
-70.3%
|
| Mar 27, 2024 |
Merck & Co Inc
MRK
|
BUY |
$145.00
Est. +11%
|
$130.18 | $129.93 |
Miss
|
$150.39
+15.5%
|
| Mar 15, 2024 |
Madrigal Pharmaceuticals Inc
MDGL
|
BUY |
$400.00
Est. +48%
|
$270.37 | $377.46 |
Miss
|
$400.43
+48.1%
|
| Feb 05, 2024 |
Apellis Pharmaceuticals Inc
APLS
|
BUY |
$80.00
Est. +17%
|
$68.16 | $42.47 |
Miss
|
$41.03
-39.8%
|
| Apr 20, 2023 |
Relay Therapeutics Inc
RLAY
|
BUY |
$12.50
Est. +1%
|
$12.35 | - | - |
$18.01
+45.8%
|
| Mar 24, 2023 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$925.00
Est. +13%
|
$819.68 | - | - |
$930.67
+13.5%
|
| Dec 19, 2022 |
Zymeworks BC Inc
ZYME
|
BUY |
$11.00
Est. +62%
|
$6.79 | - | - |
$30.94
+355.7%
|
| Sep 08, 2022 |
Regeneron Pharmaceuticals, Inc.
REGN
|
SELL |
$675.00
Est. +5%
|
$708.85 | - | - |
$930.67
-31.3%
|
| Feb 08, 2022 |
Global Blood Therapeutics Inc.
GBT
|
BUY |
$68.00
Est. +134%
|
$29.04 | $68.49 |
Bullseye Hit (±1%)
|
$68.49
+135.8%
|
| Oct 06, 2021 |
Argen X SE - ADR
ARGX
|
BUY |
$362.00
Est. +23%
|
$293.30 | - | - |
$931.38
+217.6%
|
| Oct 06, 2021 |
Sage Therapeutics Inc
SAGE
|
BUY |
$50.00
Est. +10%
|
$45.64 | - | - |
$8.68
-81.0%
|
| Oct 06, 2021 |
Horizon Therapeutics Plc
HZNP
|
BUY |
$132.00
Est. +17%
|
$113.11 | - | - |
$116.30
+2.8%
|